Lateral flow assays are immunoassay technology used for point-of-care testing to detect the presence or absence of target analytes in samples like urine, blood and saliva. It enables quick diagnosis with results available in minutes. Rising cases of infectious diseases and growing need for point-of-care testing can boost demand for lateral flow assays globally. Moreover, home based lateral flow test kits for conditions like pregnancy, glucose monitoring and COVID are witnessing huge adoption. However, regulations associated with product approval can hamper the market growth during the forecast period.
Market Dynamics:
Global lateral flow assay market growth is driven by factors like rising cases of infectious diseases like HIV, tuberculosis, and influenza which necessitates early diagnosis. Growing geriatric population susceptible to chronic diseases can also boost demand for these assays. Rising demand for point-of-care testing enabled by lateral flow assays, which provides results within minutes, can drive the market growth. Rising sales of home based test kits can offer market growth opportunities. However, factors like stringent regulatory framework and lengthy product approval process can hamper the market growth. High cost of advanced lateral flow assays can also hamper the market growth. Technological advancements to enhance accuracy and reproducibility can offer growth opportunities.
Key Features of the Study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook